Forester Capital Management’s GSK GSK Stock Holding History

Forester Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$200K	Hold	3,704	–	–	0.28%	29
2017 Q1	$195K	Hold	3,704	–	–	0.24%	31
2016 Q4	$178K	Hold	3,704	–	–	0.19%	39
2016 Q3	$200K	Hold	3,704	–	–	0.19%	47
2016 Q2	$201K	Hold	3,704	–	–	0.19%	39
2016 Q1	$214K	Buy	3,704 +1,520	+70%	+$75.7K	0.2%	42
2015 Q4	$110K	Hold	2,184	–	–	0.1%	50
2015 Q3	$105K	Hold	2,184	–	–	0.1%	51
2015 Q2	$114K	Hold	2,184	–	–	0.09%	49
2015 Q1	$126K	Hold	2,184	–	–	0.1%	50
2014 Q4	$117K	Hold	2,184	–	–	0.09%	51
2014 Q3	$125K	Hold	2,184	–	–	0.1%	49
2014 Q2	$146K	Hold	2,184	–	–	0.11%	49
2014 Q1	$146K	Buy	+2,184	New	+$148K	0.11%	48

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Forester Capital Management's GSK Position: Q2 2017 in Review

Forester Capital Management held its GSK (GSK) position steady in Q2 2017 at 3,704 shares worth $200K. The position accounts for 0.28% of the portfolio, ranked #29.

Forester Capital Management first reported a position in GSK in Q1 2014 and has held it in 14 quarters since. The position peaked at $214K in Q1 2016. 780 funds tracked by Wall St. Rank hold GSK as of Q2 2017.

Forester Capital Management held 3,704 shares of GSK worth $200K as of Q2 2017.
Forester Capital Management left its GSK share count unchanged in Q2 2017.
GSK made up 0.28% of Forester Capital Management's portfolio in Q2 2017, its #29 holding.
Forester Capital Management first reported a position in GSK in Q1 2014 and has held it in 14 quarters since.
Forester Capital Management's GSK position peaked at $214K in Q1 2016.
780 funds tracked by Wall St. Rank held GSK as of Q2 2017.

Based on Forester Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.